MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$53,558K
Free Cash flow
$97,164K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Net income
Depreciation and amortization
Stock-based compensation
Others
Negative Cash Flow Breakdown
Repurchases of common stock
Accrued compensation
Purchases of software and capita...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-04-30
2026-01-31
2025-10-31
2025-07-31
Net income
69,418
49,740
51,692
113,769
Depreciation and amortization
38,214
38,682
38,780
77,195
Stock-based compensation
19,406
19,117
20,542
33,404
Amortization of debt discount and issuance costs
277
274
271
533
Amortization of gains on derivatives
-196
-16
-
-
Loss on extinguishment of debt
-
0
0
-
Deferred taxes
10,106
-3,004
12,023
30,711
Accounts receivable, net
-1,693
12,453
79
-6,842
Prepaid expenses and other current and non-current assets
11,690
4,219
-12,206
20,650
Operating lease right-of-use assets
-1,732
-1,735
-1,711
-3,339
Accrued compensation
-31,242
15,833
10,393
-35,032
Accounts payable, accrued liabilities, and other current liabilities
-873
12,977
-7,484
-3,785
Operating lease liabilities, non-current
-2,080
-2,038
-2,012
-3,951
Other long-term liabilities
2,761
1,287
532
-1,771
Net cash provided by operating activities
97,526
117,915
138,575
200,604
Purchases of software and capitalized software development costs
15,930
9,747
10,304
26,464
Purchases of property and equipment
362
326
784
859
Acquisitions of hsa portfolios
-
0
293
0
Settlement of derivatives, net
-2,388
-1,637
-
-
Net cash used in investing activities
-13,904
-8,436
-11,381
-27,323
Repurchases of common stock
123,314
81,020
92,424
125,810
Proceeds from long-term debt
-
0
0
0
Payment of debt issuance costs
-
0
0
-
Principal payments on long-term debt
15,000
25,000
25,000
50,000
Settlement of client-held funds obligation, net
-716
-246
-25
-596
Proceeds from exercise of common stock options
418
5,963
-4,997
10,446
Net cash used in financing activities
-137,180
-99,811
-122,396
-164,768
Decrease in cash and cash equivalents
-53,558
9,668
4,798
8,513
Beginning cash and cash equivalents
318,927
309,259
295,948
-
Ending cash and cash equivalents
265,369
318,927
309,259
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$69,418K
Depreciation and
amortization
$38,214K
Stock-based compensation
$19,406K
Deferred taxes
$10,106K
Other long-term
liabilities
$2,761K
Operating lease
right-of-use assets
-$1,732K
Accounts receivable, net
-$1,693K
Amortization of debt discount
and issuance costs
$277K
Net cash provided by
operating activities
$97,526K
Canceled cashflow
$46,081K
Decrease in cash and cash
equivalents
-$53,558K
Canceled cashflow
$97,526K
Settlement of client-held
funds obligation, net
-$716K
Proceeds from exercise of
common stock options
$418K
Settlement of derivatives,
net
-$2,388K
Accrued compensation
-$31,242K
Prepaid expenses and
other current and...
$11,690K
Operating lease
liabilities, non-current
-$2,080K
Accounts payable,
accrued liabilities,...
-$873K
Amortization of gains on
derivatives
-$196K
Net cash used in
financing activities
-$137,180K
Canceled cashflow
$1,134K
Net cash used in
investing activities
-$13,904K
Canceled cashflow
$2,388K
Repurchases of common stock
$123,314K
Principal payments on
long-term debt
$15,000K
Purchases of software and
capitalized software...
$15,930K
Purchases of property and
equipment
$362K
Buy us a coffee
HEALTHEQUITY, INC. (HQY)
HEALTHEQUITY, INC. (HQY)